Individual Study / ALPHAOMEGA

The Alpha Omega Cohort

The Alpha Omega Cohort

ALPHAOMEGA logo
Initiatives -
Follow-up of the patients from the Alpha Omega Trial (designed to examine whether major cardiovascular events could be prevented by low doses of omega-3 fatty acids ). **Contact: info@alphaomegacohort.org**
Start Year
2002
Funding
Dutch Kidney Foundation, the Dutch Heart Foundation and the National Institutes of Health
Visit ALPHAOMEGA

Members

Download
Investigators Contacts
  • Leanne Küppers
    Wageningen University and Research

Design

Study design
Clinical trial cohort
Follow Up
Follow-up for cause-specific mortality is still ongoing. Data are obtained from the Dutch National Mortality Registry (Statistics Netherlands).

Marker Paper

Esmeijer K, Geleijnse JM, de Fijter JW, Giltay EJ, Kromhout D, Hoogeveen EK. Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post-Myocardial Infarction Patients: The Alpha Omega Cohort Study. Kidney Int Rep. 2018 Mar 16;3(4):879-888. doi: 10.1016/j.ekir.2018.03.005.

PUBMED 29989031

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
4,837
Number of participants with biosamples
Supplementary Information
Patients that suffered a myocardial infarction recruited from hospitals in the Netherlands

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

On the study website : https://www.alphaomegacohort.org/